CURRENT REPORT

Company

ABVC BIOPHARMA, INC.

Filed

August 13, 2019

Period of Report

August 4, 2019

Accession Number

0001213900-19-015469

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →